Target intelligence / Profile preview

Collagen-binding integrin

Molecular classification
Receptor, Integrin family, Cell adhesion molecule
01

Overview

Collagen-binding integrins are a specialized subgroup of the integrin family of cell-surface receptors, comprising four distinct alpha-beta heterodimers: alpha-1 beta-1 (VLA-1), alpha-2 beta-1 (VLA-2), alpha-10 beta-1, and alpha-11 beta-1 (Zeltz & Gullberg, 2016). These receptors are primary mediators of cell interaction with the collagenous extracellular matrix (ECM), recognizing specific triple-helical motifs such as GFOGER (Leitinger, 2011). They play fundamental roles in physiological processes including cell adhesion, migration, survival, and the regulation of ECM synthesis. In disease states, collagen-binding integrins are frequently dysregulated; for instance, alpha-1 beta-1 and alpha-2 beta-1 are involved in promoting tumor angiogenesis and metastasis, as well as driving fibrotic responses in the liver, lungs, and kidneys (Popov et al., 2011). Therapeutic targeting of these integrins, primarily through monoclonal antibodies or small molecule inhibitors like SAR113945 or BTT1023, aims to mitigate chronic inflammation and fibrotic progression by disrupting aberrant cell-collagen signaling pathways (McCall-Culbreath & Zutter, 2008).

Other names
Integrin alpha-1 beta-1Integrin alpha-2 beta-1Integrin alpha-10 beta-1Integrin alpha-11 beta-1VLA-1VLA-2Collagen receptorITGA1ITGA2ITGA10ITGA11
02

Mechanism of action

Antagonism of collagen binding and inhibition of downstream signaling pathways

03

Biological functions

Cell adhesionCell migrationSignal transductionExtracellular matrix organizationAngiogenesisWound healing
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseArthritis
05

Safety considerations

Impaired wound healingBleeding riskInhibition of physiological tissue remodeling
06

Interacting drugs

SAR113945

2 more in the full profile.

07

Biomarkers

ITGA1 expressionITGA2 expressionITGA10 expressionITGA11 expressionCirculating collagen fragments

Beyond the preview

Go deeper on Collagen-binding integrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen-binding integrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call